With the tax perhaps unlikely to ever take effect, should companies still factor it into their benefits planning and strategies?
If companies were allowed to fund HRAs for the purpose of allowing workers to buy their own insurance, some companies might do it, research suggests.
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
Millions of newly uninsured could cause a spike in costs for health-care providers, who likely would pass the costs on to private payers.
The average increase was only 2.4%, a historically low rate, according to Mercer data.
29% said the decision would be good for them, compared with 17% who said it wouldn't.
New Affordable Care Act requirements to offer health benefits to more employees didn't budge the enrollment needle at all.
Annual hikes remain historically low for a second consecutive year, partly in response to corporate benefits strategies.
No, say their human-resources leaders. Not even the individual mandate is having an impact.
